P-glycoprotein/BCRP inhibitors (Takeda Pharmaceutical)

N/A

Report date: 2025/03/20 09:22:27
NME

Base Information

Drug NameP-glycoprotein/BCRP inhibitors (Takeda Pharmaceutical)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBroad substrate specificity ATP-binding cassette transporter ABCG2 inhibitorsP-glycoprotein 1 inhibitors
TargetsBroad substrate specificity ATP-binding cassette transporter ABCG2P-glycoprotein 1
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A